Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 November 2022 | Story Edzani Nephalela | Photo Edzani Nephalela
UFS Creative Clubs
Joleen Hamilton assists learners with their activities.

In an ever-changing, increasingly complicated world, the youth must be prepared to bring knowledge and skills to solve issues, make sense of information, and know how to acquire and analyse evidence to make judgements. Science, Technology, Engineering, and Mathematics (STEM) education encourages discussions and problem-solving among students, developing practical skills and an appreciation for collaborations. 

The Social Responsibility Projects department on the UFS South Campus is running a Creative Clubs programme that speaks to STEM education and collaboration.

Opening opportunities 

The primary goal of Creatives Clubs, a MerSETA-funded programme, is to open opportunities to develop problem-solving, critical thinking, and reasoning skills. One aspect Creative Clubs focuses on is identifying potential in the pupil and supporting them in participating in the Eskom Expo for Young Scientists. Learners participate in mathematics, science, and coding activities at the club.

According to Joleen Hamilton, the coordinator and founder of Creatives Clubs, they currently host top-achieving learners in maths from eight schools from Grades 8–12 in Bloemfontein. These schools are split into two groups, which meet at the South Campus on Tuesdays and Thursdays. “We need maths daily, since it stimulates the intellect and aids problem-solving. That’s why, no matter how complicated the sum looks, keep trying and do not give up,” Hamilton said at one of the maths sessions.

Enhancing critical thinking

Matheko Thamae, also a coordinator, mentioned that this programme significantly improves maths and science outcomes for high school learners. “With a dynamic world of innovation and the 4th Industrial Revolution (4IR), the club also assists learners with critical thinking and in solving their communities’ socio-economic issues,” Thamae said. 

“Attending these sessions assists me in thinking out of the box and realising that every problem has a solution. I will continue to attend the programme so that I can find solutions to unresolved problems,” Sechaba Ramakatsa, a Grade 9 learner from Lekhulong Secondary School, said. Ramakatsa, who enjoys assisting others, aspires to be a medical doctor so that people might have better healthcare experiences.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept